Indigo Acquisition Corp. is blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase and reorganization. The company is headquartered in Miami, Florida. The company went IPO on 2025-07-01. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm intends to pursue a Business Combination with a target in any industry or geographic region. The company is not limited to target businesses in any specific industry or geographic location, although it intends to focus on opportunities with established, profitable companies with attractive market positions and/or growth potential that can leverage its management team's experience and expertise. The firm has conducted no business operations and has generated no revenue.
Indigo Acquisition Corp 주요 수익원은 Novel Treatments for B-cell Diseases이며, 최신 수익 발표에서 수익은 329,004,000입니다. 지역별로는 United States이 Indigo Acquisition Corp의 주요 시장이며, 수익은 329,004,000입니다.
Indigo Acquisition Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Indigo Acquisition Corp의 순손실은 $0입니다.